Viridian Therapeutics, Inc. (VRDN): This Small-Cap Stock Is Ready To Explode

Yahoo FinanceNov 19 21:47

Viridian Therapeutics (VRDN) Pioneering Breakthroughs in Thyroid Eye Disease

TipRanksNov 18 18:29

Viridian Therapeutics Analyst Ratings

BenzingaNov 14 18:06 · Ratings

Viridian Therapeutics: Promising FcRn Inhibitor Developments and Strong Buy Recommendation

TipRanksNov 14 15:45

H.C. Wainwright Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $34

Futu NewsNov 14 01:31 · Ratings

In-Depth Examination Of 11 Analyst Recommendations For Viridian Therapeutics

BenzingaNov 14 00:00